{"id":"https://openalex.org/W2005371095","doi":"https://doi.org/10.1046/j.1365-2265.1996.00859.x","title":"Hyperprolactinaemia and verapamil: prevalence and potential association with hypogonadism in men","display_name":"Hyperprolactinaemia and verapamil: prevalence and potential association with hypogonadism in men","publication_year":1996,"publication_date":"1996-11-01","ids":{"openalex":"https://openalex.org/W2005371095","doi":"https://doi.org/10.1046/j.1365-2265.1996.00859.x","mag":"2005371095","pmid":"https://pubmed.ncbi.nlm.nih.gov/8977754"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2265.1996.00859.x","doi":"https://doi.org/10.1046/j.1365-2265.1996.00859.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2265.1996.00859.x","pdf_url":null,"source":{"id":"https://openalex.org/S182143151","display_name":"Clinical Endocrinology","issn_l":"0300-0664","issn":["0300-0664","1365-2265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Endocrinology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069504367","display_name":"June Hart Romeo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799886695","display_name":"Veterans Health Administration","ror":"https://ror.org/05eq41471","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695"]},{"id":"https://openalex.org/I4210110978","display_name":"Louis Stokes Cleveland VA Medical Center","ror":"https://ror.org/01vrybr67","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210110978","https://openalex.org/I4210127612"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"June H. Romeo","raw_affiliation_strings":["Laboratory Medicine, Veterans' Affairs Medical Center, Cleveland, OH 44106, USA","Medical, Pharmacy, Pathology and Laboratory Medicine, and Management Support Services, Veterans' Affairs Medical Center, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory Medicine, Veterans' Affairs Medical Center, Cleveland, OH 44106, USA","institution_ids":["https://openalex.org/I2799886695","https://openalex.org/I4210110978"]},{"raw_affiliation_string":"Medical, Pharmacy, Pathology and Laboratory Medicine, and Management Support Services, Veterans' Affairs Medical Center, Cleveland, OH","institution_ids":["https://openalex.org/I2799886695","https://openalex.org/I4210110978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042450736","display_name":"Robert C. Dombrowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799886695","display_name":"Veterans Health Administration","ror":"https://ror.org/05eq41471","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695"]},{"id":"https://openalex.org/I4210110978","display_name":"Louis Stokes Cleveland VA Medical Center","ror":"https://ror.org/01vrybr67","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210110978","https://openalex.org/I4210127612"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Dombrowski","raw_affiliation_strings":["Medical, Pharmacy, Pathology and Laboratory Medicine, and Management Support Services, Veterans' Affairs Medical Center, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical, Pharmacy, Pathology and Laboratory Medicine, and Management Support Services, Veterans' Affairs Medical Center, Cleveland, OH","institution_ids":["https://openalex.org/I2799886695","https://openalex.org/I4210110978"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yun S. Kwak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799886695","display_name":"Veterans Health Administration","ror":"https://ror.org/05eq41471","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695"]},{"id":"https://openalex.org/I4210110978","display_name":"Louis Stokes Cleveland VA Medical Center","ror":"https://ror.org/01vrybr67","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210110978","https://openalex.org/I4210127612"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yun S. Kwak","raw_affiliation_strings":["Medical, Pharmacy, Pathology and Laboratory Medicine, and Management Support Services, Veterans' Affairs Medical Center, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical, Pharmacy, Pathology and Laboratory Medicine, and Management Support Services, Veterans' Affairs Medical Center, Cleveland, OH","institution_ids":["https://openalex.org/I2799886695","https://openalex.org/I4210110978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019674908","display_name":"Susan M. Fuehrer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799886695","display_name":"Veterans Health Administration","ror":"https://ror.org/05eq41471","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695"]},{"id":"https://openalex.org/I4210110978","display_name":"Louis Stokes Cleveland VA Medical Center","ror":"https://ror.org/01vrybr67","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210110978","https://openalex.org/I4210127612"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Fuehrer","raw_affiliation_strings":["Medical, Pharmacy, Pathology and Laboratory Medicine, and Management Support Services, Veterans' Affairs Medical Center, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical, Pharmacy, Pathology and Laboratory Medicine, and Management Support Services, Veterans' Affairs Medical Center, Cleveland, OH","institution_ids":["https://openalex.org/I2799886695","https://openalex.org/I4210110978"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046757708","display_name":"David Clark Aron","orcid":"https://orcid.org/0000-0002-2837-0797","observed_orcids":["https://orcid.org/0000-0002-2837-0797"]},"institutions":[{"id":"https://openalex.org/I2799886695","display_name":"Veterans Health Administration","ror":"https://ror.org/05eq41471","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695"]},{"id":"https://openalex.org/I4210110978","display_name":"Louis Stokes Cleveland VA Medical Center","ror":"https://ror.org/01vrybr67","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210110978","https://openalex.org/I4210127612"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David C. Aron","raw_affiliation_strings":["Medical, Pharmacy, Pathology and Laboratory Medicine, and Management Support Services, Veterans' Affairs Medical Center, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical, Pharmacy, Pathology and Laboratory Medicine, and Management Support Services, Veterans' Affairs Medical Center, Cleveland, OH","institution_ids":["https://openalex.org/I2799886695","https://openalex.org/I4210110978"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5046757708"],"corresponding_institution_ids":["https://openalex.org/I2799886695","https://openalex.org/I4210110978"],"apc_list":{"value":4250,"currency":"USD","value_usd":4250},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"45","issue":"5","first_page":"571","last_page":"575"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10960","display_name":"Hypothalamic control of reproductive hormones","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":1.0},{"id":"https://openalex.org/keywords/hypogonadism","display_name":"hypogonadism","score":0.9079999923706055},{"id":"https://openalex.org/keywords/testosterone-levels","display_name":"testosterone levels","score":0.6370000243186951},{"id":"https://openalex.org/keywords/men","display_name":"men","score":0.492000013589859},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.734000027179718},{"id":"https://openalex.org/keywords/prevalence","display_name":"prevalence","score":0.5429999828338623},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.5460000038146973},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6029999852180481},{"id":"https://openalex.org/keywords/male-hypogonadism","display_name":"male hypogonadism","score":0.5659999847412109},{"id":"https://openalex.org/keywords/pituitary-adenoma","display_name":"pituitary adenoma","score":0.6439999938011169},{"id":"https://openalex.org/keywords/follow-up","display_name":"follow-up","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C2781401123","wikidata":"https://www.wikidata.org/wiki/Q1433936","display_name":"Hyperprolactinaemia","level":4,"score":0.9593578577041626},{"id":"https://openalex.org/C2777022698","wikidata":"https://www.wikidata.org/wiki/Q410291","display_name":"Verapamil","level":3,"score":0.8195838928222656},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7463397979736328},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7459498047828674},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6382420659065247},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.5647130012512207},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.47256770730018616},{"id":"https://openalex.org/C2779279991","wikidata":"https://www.wikidata.org/wiki/Q6058681","display_name":"Testosterone (patch)","level":2,"score":0.43340760469436646},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4145090579986572},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.12613272666931152},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.06138277053833008},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006966","descriptor_name":"Hyperprolactinemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D008137","descriptor_name":"Longitudinal Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010044","descriptor_name":"Outpatient Clinics, Hospital","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013739","descriptor_name":"Testosterone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1365-2265.1996.00859.x","doi":"https://doi.org/10.1046/j.1365-2265.1996.00859.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2265.1996.00859.x","pdf_url":null,"source":{"id":"https://openalex.org/S182143151","display_name":"Clinical Endocrinology","issn_l":"0300-0664","issn":["0300-0664","1365-2265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Endocrinology","raw_type":"journal-article"},{"id":"pmid:8977754","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8977754","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical endocrinology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306127","display_name":"U.S. Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2413453297","https://openalex.org/W2407514336","https://openalex.org/W2399318685","https://openalex.org/W1985412031","https://openalex.org/W1997103395","https://openalex.org/W2075802347","https://openalex.org/W2111914369","https://openalex.org/W2002057086","https://openalex.org/W1856697454","https://openalex.org/W4388139806"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Verapamil":[1],"has":[2],"been":[3,10,217],"associated":[4,25,231,279],"with":[5,26,34,115,168,232,280],"hyperprolactinaemia,":[6],"but":[7],"there":[8],"have":[9,185],"no":[11],"population-based":[12],"studies.":[13],"Our":[14,343],"objective":[15],"was":[16,182,190,230,289,300,313],"to":[17,61,184,209,307],"determine":[18],"the":[19,29,40,126,153,165,193,197,305,322],"prevalence":[20,276],"and":[21,36,47,66,91,108,123,128,147,155,189,205,221,304],"degree":[22],"of":[23,42,88,113,196,277,286,296,324],"hyperprolactinaemia":[24,90,116,234,278,297,349],"verapamil":[27,104,127,154,202,215,228,281,299,312],"in":[28,39,100,125,152,178,254,262,283,321,332,339,353],"clinical":[30],"setting.":[31],"DESIGN:":[32],"Observation":[33],"cross-sectional":[35],"longitudinal":[37],"components":[38],"setting":[41],"an":[43],"urban":[44],"teaching":[45],"hospital":[46],"its":[48],"satellite":[49],"out-patient":[50],"clinics.":[51],"PATIENTS:":[52],"Male":[53],"out-patients":[54,79,288],"excluding":[55],"those":[56],"taking":[57,81,356],"other":[58],"drugs":[59],"known":[60,67],"raise":[62],"PRL,":[63],"renal":[64],"failure":[65],"primary":[68],"hypothyroidism":[69],"(1265":[70],"eligible":[71,78],"subjects).":[72],"Control":[73],"subjects":[74,102],"were":[75,98,121,143,176,199,251,330,337],"drawn":[76],"from":[77,192],"not":[80],"verapamil.":[82,342,357],"MEASUREMENTS:":[83],"Serum":[84],"PRL":[85,141,172,225,309],"levels,":[86,173],"frequency":[87],"persistent":[89,233],"total":[92],"testosterone":[93,247,328,335],"levels.":[94,226],"RESULTS:":[95],"Prolactin":[96],"levels":[97,142,248,310,329,336],"obtained":[99,177],"449":[101],"on":[103,201,341],"(35.5%":[105],"response":[106],"rate)":[107],"166":[109],"controls.":[110],"The":[111,136,242,275,294],"proportions":[112],"individuals":[114],"(PRL":[117],">":[118,237],"460":[119],"mU/l)":[120],"0.085":[122],"0.030":[124],"control":[129,156],"groups,":[130,157,334],"respectively":[131,158],"(P":[132,159],"=":[133,270],"0.012,":[134],"X2-test).":[135],"mean":[137,243],"(+/-":[138],"SD)":[139],"serum":[140,246],"267":[144],"+/-":[145,149,244,258,266],"205":[146],"203":[148],"118":[150],"mU/l":[151],"<":[160,240],"0.001,":[161],"independent":[162,272],"t-test).":[163,273],"Of":[164],"38":[166],"patients":[167,214,340,355],"previously":[169],"determined":[170],"elevated":[171],"follow-up":[174,250],"data":[175,344],"25":[179],"(65.8%);":[180],"one":[181],"found":[183],"a":[186],"pituitary":[187],"adenoma":[188],"excluded":[191],"analysis.":[194],"Fifteen":[195],"24":[198],"still":[200],"(Group":[203,219,302,315],"1)":[204,303],"14":[206],"(93.3%)":[207],"continued":[208,301],"be":[210,351],"hyperprolactinaemic.":[211],"In":[212],"9":[213],"had":[216,223],"discontinued":[218,314],"2)":[220,316],"all":[222],"normal":[224,308],"Continued":[227],"use":[229,282],"(odds":[235],"ratio":[236],"120,":[238],"P":[239,269],"0.00001).":[241],"SD":[245],"at":[249],"significantly":[252],"lower":[253,338],"Group":[255,263],"1":[256],"(6.16":[257],"2.52":[259],"nmol/l)":[260],"than":[261],"2":[264],"(9.42":[265],"3.92":[267],"nmol/l,":[268],"0.029,":[271],"CONCLUSIONS:":[274],"this":[284],"study":[285],"male":[287,354],"8.5%":[290],"(95%":[291],"CI":[292],"5.9-11.1%).":[293],"persistence":[295],"when":[298,311],"return":[306],"confirm":[317],"verapamil's":[318],"causal":[319],"role":[320],"development":[323],"hyperprolactinaemia.":[325],"While":[326],"low":[327],"common":[331],"both":[333],"suggest":[345],"that":[346],"screening":[347],"for":[348],"should":[350],"considered":[352]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}